Throughout the last three months, 15 analysts have evaluated Axsome Therapeutics (NASDAQ:AXSM), offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 9 | 6 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 3 | 1 | 0 | 0 | 0 |
2M Ago | 0 | 2 | 0 | 0 | 0 |
3M Ago | 6 | 2 | 0 | 0 | 0 |
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $137.8, a high estimate of $190.00, and a low estimate of $106.00. Witnessing a positive shift, the current average has risen by 7.07% from the previous average price target of $128.70.
Breaking Down Analyst Ratings: A Detailed Examination
An in-depth analysis of...
ログインすると全部閲覧できます。
ログイン